Vasa Therapeutics

Vasa Therapeutics is a San Diego-based biotechnology company focused on discovering and developing therapeutics targeting the pathophysiology of cardiovascular aging.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded: 2019Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 1 supported appearance ↗Source: RevenueBase lists

The company at a glance

What does Vasa Therapeutics do?

The company has three active preclinical programs.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Long-acting apelin peptide analogs

The analogs are intended for combination treatment with incretins in obesity patients at risk of skeletal muscle loss or cardiovascular disease.

Source: LinkedIn company description · Retrieved October 13, 2026

CamKIId inhibitor

The inhibitor is for heart failure and life-threatening arrhythmias.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#15OF 25

Worldwide

Hypertrophic cardiomyopathy therapy companies

Snapshot: September 19, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Vasa Therapeutics

#15 Hypertrophic cardiomyopathy therapy companies

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/browse/hypertrophic-cardiomyopathy-therapy-companies" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/vasatherapeutics/recognition-companies-browse-hypertrophic-cardiomyopathy-therapy-companies-20260920-9056ef42f807fb224d330d88608db111183c984a96a73fe2fbc8abd0db7a3838.svg" alt="Vasa Therapeutics listed #15 on Hypertrophic cardiomyopathy therapy companies, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 1, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →